MedPath

An open randomised study to assess the efficacy of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever

Completed
Conditions
Typhoid fever
Infections and Infestations
Registration Number
ISRCTN67946944
Lead Sponsor
niversity of Oxford (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients will be eligible if they have suspected or culture proven enteric fever provided:
1. They give fully informed consent
2. They are not obtunded not jaundiced
3. There are no signs of gastrointestinal (GI) bleeding or any other evidence of severity (see below)
4. No history of hypersensitivity to either of the trial drugs
5. No treatment with a quinolone or 3rd generation cephalosporin or macrolide within one week of hospital admission
6. They are not pregnant

Exclusion Criteria

1. Pregnancy or lactation
2. Any signs of symptoms of severe disease
3. No informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath